Osteoprotegerin (OPG) acts as an endogenous decoy receptor in tumour necrosis factor-related apoptosis-inducing ligand (TRAIL)-mediated apoptosis of fibroblast-like synovial cells (Q60809321)

From Wikidata

Jump to navigation Jump to search

scientific article published on 01 August 2004

Language	Label	Description	Also known as
English	Osteoprotegerin (OPG) acts as an endogenous decoy receptor in tumour necrosis factor-related apoptosis-inducing ligand (TRAIL)-mediated apoptosis of fibroblast-like synovial cells	scientific article published on 01 August 2004

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15270863%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Osteoprotegerin (OPG) acts as an endogenous decoy receptor in tumour necrosis factor-related apoptosis-inducing ligand (TRAIL)-mediated apoptosis of fibroblast-like synovial cells (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15270863%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

0 references

0 references

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15270863%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

author name string

T Miyashita

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15270863%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

A Kawakami

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15270863%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

T Nakashima

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15270863%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

S Yamasaki

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15270863%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

F Tanaka

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15270863%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

M Kamachi

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15270863%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

H Ida

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15270863%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

K Migita

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15270863%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

T Origuchi

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15270863%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

K Nakao

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15270863%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

K Eguchi

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15270863%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

language of work or name

0 references

publication date

1 August 2004

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15270863%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Clinical and Experimental Immunology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15270863%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

137

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15270863%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15270863%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

430-436

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15270863%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Elevated levels of osteoprotegerin (OPG) and hepatocyte growth factor (HGF) in rheumatoid arthritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/15270863

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

TR1, a new member of the tumor necrosis factor receptor superfamily, induces fibroblast proliferation and inhibits osteoclastogenesis and bone resorption

1 reference

https://pubmed.ncbi.nlm.nih.gov/15270863

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

TRAIL-R2 (DR5) mediates apoptosis of synovial fibroblasts in rheumatoid arthritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/15270863

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Akt is an endogenous inhibitor toward tumor necrosis factor-related apoptosis inducing ligand-mediated apoptosis in rheumatoid synovial cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/15270863

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/15270863

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cytokines and acute phase proteins in rheumatoid arthritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/15270863

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Fas antigen expression on synovial cells was down-regulated by interleukin 1 beta

1 reference

https://pubmed.ncbi.nlm.nih.gov/15270863

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Inhibition of Fas antigen-mediated apoptosis of rheumatoid synovial cells in vitro by transforming growth factor beta 1

1 reference

https://pubmed.ncbi.nlm.nih.gov/15270863

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The receptor for the cytotoxic ligand TRAIL

1 reference

https://pubmed.ncbi.nlm.nih.gov/15270863

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Osteoprotegerin: a novel secreted protein involved in the regulation of bone density

1 reference

https://pubmed.ncbi.nlm.nih.gov/15270863

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Isolation of a novel cytokine from human fibroblasts that specifically inhibits osteoclastogenesis

1 reference

https://pubmed.ncbi.nlm.nih.gov/15270863

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

An antagonist decoy receptor and a death domain-containing receptor for TRAIL

1 reference

https://pubmed.ncbi.nlm.nih.gov/15270863

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Apoptosis in the rheumatic diseases

1 reference

https://pubmed.ncbi.nlm.nih.gov/15270863

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Regulation of synovial cell apoptosis by proteasome inhibitor

1 reference

https://pubmed.ncbi.nlm.nih.gov/15270863

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand

1 reference

https://pubmed.ncbi.nlm.nih.gov/15270863

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) is an inhibitor of autoimmune inflammation and cell cycle progression

1 reference

https://pubmed.ncbi.nlm.nih.gov/15270863

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Osteoprotegerin Is an αvβ3-induced, NF-κB-dependent Survival Factor for Endothelial Cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/15270863

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Temperature-sensitive differential affinity of TRAIL for its receptors. DR5 is the highest affinity receptor

1 reference

https://pubmed.ncbi.nlm.nih.gov/15270863

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Activated human T cells directly induce osteoclastogenesis from human monocytes: possible role of T cells in bone destruction in rheumatoid arthritis patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/15270863

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Receptor activator of NF-kappa B and osteoprotegerin expression by human microvascular endothelial cells, regulation by inflammatory cytokines, and role in human osteoclastogenesis

1 reference

https://pubmed.ncbi.nlm.nih.gov/15270863

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identity of osteoclastogenesis inhibitory factor (OCIF) and osteoprotegerin (OPG): a mechanism by which OPG/OCIF inhibits osteoclastogenesis in vitro

1 reference

https://pubmed.ncbi.nlm.nih.gov/15270863

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Characterization of monomeric and homodimeric forms of osteoclastogenesis inhibitory factor

1 reference

https://pubmed.ncbi.nlm.nih.gov/15270863

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Osteoprotegerin is a receptor for the cytotoxic ligand TRAIL.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15270863

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High levels of osteoprotegerin and soluble receptor activator of nuclear factor kappa B ligand in serum of rheumatoid arthritis patients and their normalization after anti-tumor necrosis factor alpha treatment

1 reference

https://pubmed.ncbi.nlm.nih.gov/15270863

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q60809321&oldid=2111004857"